InvestorsHub Logo
Followers 84
Posts 1928
Boards Moderated 0
Alias Born 03/05/2014

Re: Blueheel1 post# 47058

Saturday, 10/12/2019 10:41:44 PM

Saturday, October 12, 2019 10:41:44 PM

Post# of 233151
I feel your pain BH. IMO most Long’s are growing increasingly impatient with Nader’s style, inflated compensation, shrinking SP, and inability to deliver on a financial deal that could get us over the hump.

I’m of the opinion that it would be wise to take the best deal on the table with the most upfront cash —maybe that deal is in the works right now. That would get us to FDA approval for HIV Combo. Then we have the ability to begin commercializing and generating revenue, push the Mono and TNBC trials and hopefully get the interim data we believe is there.

Point is I think Nader should get real about Leronlimab’s CURRENT valuation rather than constantly pitching the valuation that is just around the corner. Nobody is buying his worn out story and the SP is proof. The result is a dirt road that continues to get longer and wider with no money to pave any part of it.

Hopefully his latest words deliver. Problem is we have been doing this dance for years and one becomes numb to believing this will be any different than the golden quarter that was promised years ago.

Science is still stronger than ever. Progress is confined to an empty bank account.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News